Stroma-targeted palliative tumor therapy with biomodulators

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Christian HafnerThomas Vogt

Abstract

In search of new strategies for the therapy of advanced tumors stroma-targeted approaches have been discussed recently, especially antiangiogenic therapies. It has turned out that some biomodulating drugs exhibit also effects against tumors beyond their original non-oncologic indication. Among these drugs are for example thalidomide,COX-2 inhibitors, PPARgamma agonists (thiazolidindiones) and mTOR antagonists (rapamycin). The antitumor efficacy of these therapeutics is fundamentally based on indirect effects on the stroma of the tumors. Combination therapies of these therapeutics seem to be superior to the use of single agents. These new biomodulating therapy approaches represent an interesting option for the palliative treatment of advanced tumors, especially as a supplement or extension of established chemo- and immunotherapeutic therapies, since they can be performed in an outpatient setting, the observed side effects are usually mild, and the therapies are therefore well accepted by the patients.

References

Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R F LittleR Yarchoan
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Jen HwuAlan N Houghton
Sep 27, 2003·Melanoma Research·Wojciech PlachaPiotr Laidler
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jul 3, 2004·The Lancet Oncology·Christian GrommesMichael T Heneka
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janice P Dutcher

❮ Previous
Next ❯

Citations

Jun 19, 2008·Journal of Cancer Research and Clinical Oncology·Dorothée NashanLeena Bruckner-Tuderman
Aug 3, 2012·Actas dermo-sifiliográficas·M C Fernández-Antón MartínezR M Suárez Fernández
Nov 9, 2010·Dermatologic Therapy·Dorothée NashanSebastian Reichenberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.